Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 13, 2017 XRAY P 77,000 $66.04 $5,085,080 119,270 Direct +182.16% Acquired -86.9% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 6, 2024 PIIIW Stock Option (Right to Buy) Class A Common Stock (965,279) $0.55 June 6, 2034 965,279 Acquired
March 24, 2022 PIIIW Stock Option (Right to Buy) Class A Common Stock (200,000) $7.95 March 24, 2032 200,000 Acquired
March 24, 2022 PIIIW Stock Option (Right to Buy) Class A Common Stock (171,069) $7.95 March 24, 2032 171,069 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 10, 2017 XRAY Common Stock 42,208 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $780,822 $2,500,000 · · · · · $5,780,802

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.